RNAC
Cartesian Therapeutics Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$250.77M
P/E Ratio
—
EPS
$-5.80
Beta
0.78
52W High
$15.57
52W Low
$5.60
50-Day MA
$6.89
200-Day MA
$7.73
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
25.06
PEG Ratio
0.00
About Cartesian Therapeutics Inc.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | $1.77M |
| Gross Profit (TTM) | $-61.05M |
| EBITDA | $-88.90M |
| Operating Margin | -33973.00% |
| Return on Equity | -7029.00% |
| Return on Assets | -16.40% |
| Revenue/Share (TTM) | $0.07 |
| Book Value | $-5.19 |
| Price-to-Book | 31.26 |
| Price-to-Sales (TTM) | 141.28 |
| EV/Revenue | 73.26 |
| EV/EBITDA | 1.77 |
| Quarterly Earnings Growth (YoY) | -7.40% |
| Quarterly Revenue Growth (YoY) | -92.90% |
| Shares Outstanding | $29.38M |
| Float | $10.63M |
| % Insiders | 53.68% |
| % Institutions | 24.50% |
Historical Volatility
HV 10-Day
157.40%
HV 20-Day
137.21%
HV 30-Day
122.68%
HV 60-Day
97.93%
HV Rank
100.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($34.57 target)
1
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026